Prognostic molecular markers in non-small cell lung cancer (Q34447423)

2 August 2017

1 reference

title

Prognostic molecular markers in non-small cell lung cancer (English)

1 reference

2 August 2017

1 reference

1

Nikliński J

1 reference

2 August 2017

Niklińska W

2

1 reference

2 August 2017

Laudanski J

series ordinal

3

1 reference

2 August 2017

Chyczewska E

series ordinal

4

1 reference

2 August 2017

Chyczewski L

series ordinal

5

1 reference

2 August 2017

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

34 Suppl 2

1 reference

2 August 2017

S53-8

1 reference

2 August 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

The future of prognostic factors in outcome prediction for patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Clinical tumour markers in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Molecular pathogenesis of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

A simple p53 functional assay for screening cell lines, blood, and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

p21WAF1/CIP1 expression in primary lung adenocarcinomas: heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900345-2

7 January 2021

10.1016/S0169-5002(01)00345-2

Identifiers

DOI

1 reference

2 August 2017

1 reference